Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 4Unknown 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 5INDUSTRY 2

Study Type

Observational 4Interventional 3

Sponsor

Conditions

Breast Neoplasms 13138Neoplasms 10481Carcinoma, Non-Small-Cell Lung 6874Prostatic Neoplasms 6268Colorectal Neoplasms 5948Lung Neoplasms 5105Multiple Myeloma 3577Pancreatic Neoplasms 3563Leukemia, Myeloid, Acute 3510Neoplasm Metastasis 3508Carcinoma, Hepatocellular 3273Ovarian Neoplasms 3168Melanoma 3141Stomach Neoplasms 3057Lymphoma 2983Head and Neck Neoplasms 2604Recurrence 2557Precursor Cell Lymphoblastic Leukemia-Lymphoma 2499Leukemia 2362Colonic Neoplasms 2328Brain Neoplasms 2313Lymphoma, Non-Hodgkin 2269Rectal Neoplasms 2192Uterine Cervical Neoplasms 2191Glioblastoma 2016Leukemia, Lymphocytic, Chronic, B-Cell 1992Carcinoma, Renal Cell 1913Squamous Cell Carcinoma of Head and Neck 1880Lymphoma, Follicular 1848Esophageal Neoplasms 1801

Interventions

Diagnostic Tests, Routine 2Longitudinal Studies 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Hereditary Cancer × Clear all
NCT06157801 2026-03-04

Evaluation of Hereditary Cancer Educational Videos

M.D. Anderson Cancer Center

Active not recruiting
43 enrolled

Hereditary Cancer

NCT06073626 2025-10-28

Addressing Genomic Disparities in Cancer Survivors

Rutgers, The State University of New Jersey

Phase NA Recruiting
428 enrolled

Hereditary Cancer

NCT06284330 2025-09-05

CHARGE

University of Texas Southwestern Medical Center

Phase NA Completed
108 enrolled

Hereditary Cancer

NCT06378749 2025-05-21

PreCharge

Pro-Change Behavior Systems

Phase NA Completed
138 enrolled 9 charts

Hereditary Cancer

NCT03319290 2019-01-23

Increase Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategies

Data Collection Analysis Business Management

Unknown
2,000 enrolled

Hereditary Cancer

NCT03067389 2019-01-15

Combined Breast Cancer Risk Study

Myriad Genetic Laboratories, Inc.

Completed
553 enrolled

Hereditary Cancer

NCT03081455 2017-08-08

Impact of a Process Intervention on Screening and Testing Outcomes for Common Hereditary Cancer Syndromes

Myriad Genetic Laboratories, Inc.

Completed
145 enrolled

Hereditary Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡